
Shanghai operating company of WuXi Biologics, the global biologics contract research, development and manufacturing organisation headquartered in Wuxi, Jiangsu and listed in Hong Kong. Provides an open-access technology platform covering discovery, development and manufacturing of biologics - monoclonal antibodies, bispecific antibodies, antibody-drug conjugates, fusion proteins and vaccines - including cell line and process development, analytical and formulation development, clinical and commercial drug substance and drug product manufacturing and regulatory support for partners worldwide.
View Company Profile
Leave your rating